Lipid formulations of amphotericin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Transplants Membrane Microdomains

Organisms24

Candida Candida albicans Aspergillus fumigatus Aspergillus Cryptococcus neoformans Fungi Rhizopus Mucorales Scedosporium Absidia Trichosporon Candida glabrata Candida tropicalis Paecilomyces Aspergillus flavus Leishmania donovani Fusarium Cryptococcus Histoplasma Rabbits Coccidioides Mice, Inbred BALB C Mitosporic Fungi Pseudallescheria

Diseases21

Central Nervous System Fungal Infections Aspergillosis Mycoses Leishmaniasis, Visceral Candidiasis Mucormycosis Lung Diseases, Fungal Meningitis, Cryptococcal Cryptococcosis Zygomycosis Fungemia Histoplasmosis Neutropenia Coccidioidomycosis Blastomycosis Meningitis, Fungal Opportunistic Infections Mycetoma Dermatomycoses Eye Infections, Fungal Invasive Pulmonary Aspergillosis

Chemicals and Drugs49

Amphotericin B Antifungal Agents Lipids Deoxycholic Acid Phosphatidylglycerols Liposomes Antiprotozoal Agents Drug Carriers Drug Combinations Phosphatidylcholines Lipid A Itraconazole Flucytosine Fluconazole Triazoles Echinocandins Nystatin Lipid Bilayers Excipients Delayed-Action Preparations Dosage Forms Ergosterol Emulsions Miconazole Tablets Peptides, Cyclic Lipopeptides Polyenes Lipid Peroxides Fat Emulsions, Intravenous Pyrimidines Ketoconazole Tuftsin Natamycin Colloids Suspensions Azoles Pharmaceutical Vehicles Cholesterol Capsules Phospholipids Powders Culture Media Pharmaceutical Solutions Sterols Methylcellulose Micelles Surface-Active Agents Membranes, Artificial

Analytical, Diagnostic and Therapeutic Techniques and Equipment17

Drug Carriers Drug Compounding Microbial Sensitivity Tests Treatment Outcome Delayed-Action Preparations Dosage Forms Drug Stability Drug Delivery Systems Technology, Pharmaceutical Pharmaceutical Vehicles Administration, Oral Drug Therapy, Combination Colony Count, Microbial Culture Media Chromatography, High Pressure Liquid Injections, Intravenous Administration, Topical

Phenomena and Processes13

Lipid Metabolism Lipid Peroxidation Drug Resistance, Fungal Particle Size Immunocompromised Host Solubility Therapeutic Equivalency Drug Resistance, Multiple, Fungal Biological Availability Dose-Response Relationship, Drug Drug Synergism Time Factors Skin Absorption

Disciplines and Occupations2

Chemistry, Pharmaceutical Technology, Pharmaceutical

Technology, Industry, Agriculture5

Liposomes Lipid Bilayers Technology, Pharmaceutical Nanoparticles Membranes, Artificial

Health Care1

Treatment Outcome

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Health Care

Amphotericin B Antifungal Agents Chemistry, Pharmaceutical Lipids Deoxycholic Acid Phosphatidylglycerols Liposomes Central Nervous System Fungal Infections Aspergillosis Antiprotozoal Agents Drug Carriers Drug Combinations Mycoses Transplants Drug Compounding Leishmaniasis, Visceral Phosphatidylcholines Lipid Metabolism Lipid A Itraconazole Candidiasis Flucytosine Fluconazole Triazoles Candida Echinocandins Nystatin Lipid Bilayers Microbial Sensitivity Tests Candida albicans Mucormycosis Aspergillus fumigatus Aspergillus Treatment Outcome Excipients Lung Diseases, Fungal Lipid Peroxidation Drug Resistance, Fungal Delayed-Action Preparations Dosage Forms Ergosterol Meningitis, Cryptococcal Emulsions Miconazole Tablets Peptides, Cyclic Lipopeptides Drug Stability Cryptococcosis Cryptococcus neoformans Zygomycosis Polyenes Fungi Fungemia Lipid Peroxides Rhizopus Fat Emulsions, Intravenous Mucorales Particle Size Histoplasmosis Neutropenia Pyrimidines Ketoconazole Tuftsin Natamycin Drug Delivery Systems Colloids Immunocompromised Host Suspensions Scedosporium Technology, Pharmaceutical Absidia Trichosporon Coccidioidomycosis Azoles Blastomycosis Solubility Pharmaceutical Vehicles Cholesterol Meningitis, Fungal Capsules Phospholipids Administration, Oral Therapeutic Equivalency Drug Therapy, Combination Drug Resistance, Multiple, Fungal Colony Count, Microbial Biological Availability Powders Dose-Response Relationship, Drug Candida glabrata Opportunistic Infections Nanoparticles Candida tropicalis Paecilomyces Drug Synergism Mycetoma Dermatomycoses Aspergillus flavus Leishmania donovani

No FAQ available that match "lipid formulations of amphotericin"